Page last updated: 2024-10-27

flumazenil and Anemia, Iron-Deficiency

flumazenil has been researched along with Anemia, Iron-Deficiency in 1 studies

Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.

Anemia, Iron-Deficiency: Anemia characterized by decreased or absent iron stores, low serum iron concentration, low transferrin saturation, and low hemoglobin concentration or hematocrit value. The erythrocytes are hypochromic and microcytic and the iron binding capacity is increased.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Redondo, MJ1
Guisasola, FJ1

Other Studies

1 other study available for flumazenil and Anemia, Iron-Deficiency

ArticleYear
An unknown risk group of lead poisoning: the gypsy children.
    European journal of pediatrics, 1995, Volume: 154, Issue:3

    Topics: Adolescent; Anemia, Iron-Deficiency; Case-Control Studies; Child; Child, Preschool; Female; Humans;

1995